Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Bobillo

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Hematology. American Society of Hematology. Education Program|December 9, 2022
CNS prophylaxis in aggressive B-cell lymphomaMatthew R Wilson, Sabela Bobillo, Kate Cwynarski
Bone Marrow Transplantation|March 20, 2021
Use of checkpoint inhibitors in patients with lymphoid malignancies receiving allogeneic cell transplantation: a reviewSabela Bobillo, Juan Camilo Nieto, Pere Barba
Current Opinion in Oncology|August 8, 2023
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphomaSabela Bobillo, Matthew R Wilson, Kate Cwynarski
Haematologica|November 17, 2022
Prevention and management of secondary central nervous system lymphomaSabela Bobillo, Jahanzaib Khwaja, Andrés J M Ferreri, et al.
Transfusion|September 24, 2022
Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experienceMoraima Jiménez, Sabela Bobillo, Verónica Pons, et al.
Hematological Oncology|June 29, 2023
Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapsePaola Ghione, Katharine L Lewis, Sabela Bobillo, et al.
Annals of Hematology|March 25, 2018
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomesJulia Montoro, Laura Gallur, Brayan Merchán, et al.
Annals of Hematology|July 8, 2021
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapyGloria Iacoboni, Marc Simó, Guillermo Villacampa, et al.
Blood Advances|August 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progressionPau Abrisqueta, Daniel Medina, Guillermo Villacampa, et al.
The Lancet. Oncology|September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphomaToby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Hematology. American Society of Hematology. Education Program|December 9, 2022
CNS prophylaxis in aggressive B-cell lymphomaMatthew R Wilson, Sabela Bobillo, Kate Cwynarski
Bone Marrow Transplantation|March 20, 2021
Use of checkpoint inhibitors in patients with lymphoid malignancies receiving allogeneic cell transplantation: a reviewSabela Bobillo, Juan Camilo Nieto, Pere Barba
Current Opinion in Oncology|August 8, 2023
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphomaSabela Bobillo, Matthew R Wilson, Kate Cwynarski
Haematologica|November 17, 2022
Prevention and management of secondary central nervous system lymphomaSabela Bobillo, Jahanzaib Khwaja, Andrés J M Ferreri, et al.
Transfusion|September 24, 2022
Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experienceMoraima Jiménez, Sabela Bobillo, Verónica Pons, et al.
Hematological Oncology|June 29, 2023
Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapsePaola Ghione, Katharine L Lewis, Sabela Bobillo, et al.
Annals of Hematology|March 25, 2018
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomesJulia Montoro, Laura Gallur, Brayan Merchán, et al.
Annals of Hematology|July 8, 2021
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapyGloria Iacoboni, Marc Simó, Guillermo Villacampa, et al.
Blood Advances|August 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progressionPau Abrisqueta, Daniel Medina, Guillermo Villacampa, et al.
The Lancet. Oncology|September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphomaToby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
Pageof 4